Pustular psoriasis following treatment with biologics among patients with plaque psoriasis: a nationwide cohort study
Paradoxical reactions following treatment with biologics are well-documented adverse effects. The risks of paradoxical plaque and pustular psoriasis among patients with various other immune-mediated inflammatory diseases following treatment with tumour necrosis factor α inhibitors (TNFi) have been studied. Although case reports describe the emergence of pustular psoriasis in patients treated with all class of biologics for plaque psoriasis, population-level studies assessing risks between biologics are needed.
Authors
- Lone Skov (ORCID: https://orcid.org/0000-0002-4784-9680)
- Christopher G. Bunick (ORCID: https://orcid.org/0000-0002-4011-8308)
- Diljit Kaur‐Knudsen
- Michel Gilliet (ORCID: https://orcid.org/0000-0002-4609-3762)
- Claus Otto Carl Zachariae (ORCID: https://orcid.org/0000-0001-5506-1319)
- Nikolai Loft (ORCID: https://orcid.org/0000-0002-2950-3280)
Institutions
- University of Copenhagen (DK)
- Gentofte Hospital (DK)
- Yale University (US)
- University of Lausanne (CH)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-11-07
- DOI
- https://doi.org/10.1093/bjd/ljaf448
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00